Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Thus, the need for a potent, safe and well-tolerated antiviral drug remains. This review focuses on target molecules that are implicated in the development of innovative anticytomegaloviral ...

A new study has uncovered a molecular mechanism by which rice cells perceive viral infections and initiate antiviral response ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

They found that the antiviral treatment, especially when given early in the course of the infection, can leave behind target cells that can still be infected with the virus. In addition ...

may be expressed as these could also represent suitable antiviral targets. The virus structural proteins L1 and L2 may be targets for therapy but only for inhibition of reinfection. This type of ...

Cidara Therapeutics has published preclinical data in Nature Microbiology that demonstrates the potential of CD388, their investigational drug-Fc conjugate, as a universal antiviral for preventing ...

Kenneth and colleagues can use this new tool to predict where to target drugs that would best block its replication, and how to design those drugs. Though we already have antivirals for COVID-19, in a ...

Researchers first discovered that SMYD3 negatively regulated innate antiviral responses induced by both RNA and DNA viruses, and the suppressive role of SMYD3 in antiviral innate immunity depended ...

Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune statusSAN DIEGO, March 17, ...